Teva Pharmaceutical's CEO Levin Resigns

Oct 30, 2013

Bloomberg Businessweek

Teva Pharmaceutical Industries Ltd., one of the world's largest generic drugmakers, said President and CEO Jeremy Levin has agreed to resign less than two years into the job. The Israeli company named Chief Financial Officer Eyal Desheh an interim replacement and formed a committee to start searching for a permanent successor. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments